While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults.

The American Academy of Pediatrics (AAP) has assembled nearly 200 stories and dozens of testimonials on the horrors of ...

Few data are available to evaluate this policy. Aims: To examine the management and clinical course in relation to antibiotic therapy of a large unselected cohort of children with pneumococcal ...

Young children are especially vulnerable ... into Dhaka Shishu at the age of three with what turned out to be pneumococcal meningitis, was propped up in a small plastic armchair beside the ...

Here's what bacterial meningitis is, how it's different from viral and other types of meningitis, and what treatment can be ...

Nearly one third of adults in a Swedish cohort who contracted bacterial meningitis as children have permanent neurologic disabilities ... underscore the need to educate parents on the benefits of ...

In children with a recurrent episode of bacterial meningitis, the median age of the first recurrence ... W and Y (MenACWY), 115 (1%) for 7-valent pneumococcal conjugate vaccine (PCV7) and 66 (1%) for ...

What is the pneumococcal vaccine? This vaccine protects against pneumococcal infections, which mostly happen in children younger than age 5 and can lead to some dangerous childhood diseases.

Children with cochlear implants have a higher risk than ... Kids with cochlear implants are at higher risk of getting meningitis caused by pneumococcal bacteria. The type of vaccine and number of ...

Background: The impact of the heptavalent-pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in Europe has not yet been assessed. Objective: To determine whether ...

Pneumococcal (except meningitis) children: 600,000 units; adults 1.2 million units; give every 2–3 days until afebrile for 48hrs. Not for IV use; do not inject into or near an artery or nerve.